Patient Reported Outcomes Version of CTCAE Expanded Prostate Cancer Index Composite, Sexual Medications/Devices Supplement CPTAC Terminology CPTAC Baseline Medical Forms Terminology CPTAC Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma Baseline Form GDC Terminology CPTAC Clear Cell Renal Cell Carcinoma Baseline Form Risk Factor EWS Authorized Value Terminology EWS Biopsy/Surgical Procedures Table GDC Value Terminology Reflux Treatment Type Indicator CRF4 Treatment Additional Surgeries Table CRF4 Treatment Surgery Table CRF6 DIPG Imaging Assessment Signal Characteristics Table CRF6 DMG Imaging Assessment Signal Characteristics Table CRF7 Pathology Review Table ACC/AHA Cardiovascular and Noncardiovascular Complications of COVID-19 Terminology Appendix 7: Diagnostic Procedures Terminology Appendix 8: Pharmacological Therapy Terminology Appendix 9: Therapeutic and Supportive Procedures for COVID-19 Terminology Mechanical Support Terminology Therapies for Supportive Care During COVID-19 Infection Terminology ACC/AHA COVID-19 Appendix Authorized Values Operational Ontology for Radiation Oncology Prostate Cancer Terminology First Post-treatment Event Average Number of Exercise Days per Week Question Extrathyroid Extent Indicator PRO-CTCAE Version 1.0 Questionnaire Terminology PRO-CTCAE Attribute Value Terminology International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Terminology ICH M11 Terminology ICH M11 Independent Committee Name Value Set Terminology General Qualifier Localization Lymph Node by Anatomic Site None C0549184 GDC DIPG/DMG CDISC None C41132 No person or thing, nobody, not any. (NCI) No person or thing, nobody, not any. OORO ICH PCDC No Treatment None ACC/AHA None None at all No person or thing, nobody, not any. CPTAC Functional Concept No abnormalities related to cardiovascular diseases NONE PRO-CTCAE None Immunosuppressant Clinical Data Interchange Standards Consortium Terminology CDISC SDTM Control Type Terminology CDISC SDTM Terminology Clinical or Research Assessment Answer